RON BENTSUR

CIK 1251213 · Chairman & CEO · last filed 2026-01-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$39.47M

Companies

5

Total Filings

114

Lifetime Open-Market Net

-$10.24M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NVCT Chairman & CEO 3,675,924 $10.71 $39.37M $2.48M 50 2026-01-09
XAIR Director 144,736 $0.37 $53.7K -$1.49M 25 2024-11-26
STEMLINE THERAPEUTICS INC (STML) Delisted Director 0 -$22.4K 8 2020-06-10
KERYX BIOPHARMACEUTICALS INC (KERX) Delisted Chief Executive Officer 777,209 -$11.23M 29 2015-04-08
XTLB CEO 20,101 $2.13 $42.8K $19.9K 1 2007-08-21

Recent Filings · Page 4 of 12

114 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-11-30 NVCT Buy (P) +150 $1.1K EDGAR
2022-11-29 NVCT Buy (P) +450 $3.3K EDGAR
2022-11-21 NVCT Buy (P) +750 $5.4K EDGAR
2022-11-16 NVCT Buy (P) +1,000 $7.1K EDGAR
2022-10-03 NVCT Buy (P) +1,000 $7.3K EDGAR
2022-09-27 NVCT Buy (P) +1,500 $11.8K EDGAR
2022-09-06 NVCT Buy (P) +1,700 $14.1K EDGAR
2022-08-30 NVCT Buy (P) +1,500 $13.6K EDGAR
2022-08-22 NVCT Buy (P) +19,426 $168.7K EDGAR
2022-08-16 NVCT Buy (P) +19,669 $165.2K EDGAR
Showing 3140 of 114
Page 4 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.